Ignite Creation Date:
2024-10-25 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06553287
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-10
Brief Title:
Safety Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase Ib Randomized Double-Blind Vehicle-Controlled Dose Escalation Study to Evaluate the Safety Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults Patients With Mild to Moderate Atopic Dermatitis
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the Safety Tolerability and Pharmacokinetics of LNK01004 ointment 03 10 and 15 vs vehicle twice daily BID in Adults Patients with Atopic Dermatitis
Detailed Description:
This is a multicenter randomized double-blind vehicle-controlled dose-escalation study to Evaluate the Safety Tolerability and Pharmacokinetics of LNK01004 ointment twice daily BID in participants with Mild to Moderate atopic dermatitis as compared with vehicle cream BID
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None